Stress urinary incontinence

Sling procedures have been performed for over 90 years and may offer a good solution for patients with severe stress incontinence and weakened pelvic floor muscles. A sling procedure can create the urethral compression necessary to achieve bladder control. While all appropriate non-surgical treatments should be tried before deciding on a surgical procedure.

Coloplast offers a variety of slings to treat stress incontinence, via the transobturator, suprapubic, and pubovaginal techniques for sling placement.

Fixation-less slings

Transobturator and suprapubic slings, also called fixation-less slings, are used to treat incontinence by supporting the urethra. These are synthetic slings placed in a U-shape or hammock position, cradling the urethra and bladder neck. However, the sling is held in place through natural tissue growth rather than screws or sutures. The Coloplast

Aris® sling systems are examples of fixationless slings. The Altis single incision sling uses the same proven material of the Aris.

Another option is a pubovaginal sling. This procedure can also create enough compression on the urethra to help the patient retain bladder control.  Historically, the pubovaginal sling was made from the patient’s own tissue. However, Coloplast’s Suspend® fascia lata and Axis™ dermis are natural and reliable cadaveric tissues for use in urethral sling procedures. They offer a proven alternative to the use of the patient’s own tissue for a sling to suspend the urethra and bladder neck.

Lightest on the market

Coloplast’s range of slings allows doctors to choose the correct sling based on the patient’s anatomy, preferences and severity of incontinence. They are the lightest slings on the market and have low elasticity, allowing for a reproducible placement and tensioning without sling deformation.

Read more about Coloplast’s synthetic sling options for stress urinary incontinence. 

Stress urinary incontinence (SUI) is the brief involuntary leakage of urine due to effort or exertions such as sneezing or coughing. SUI has two principal causes: urethral hypermobility and weakness of the urethral sphincter; a condition known as intrinsic sphincter deficiency (ISD).

Hypermobility and ISD coexist in the majority of SUI patients. For women with ISD, injection therapy provides a relatively low-risk and minimally invasive treatment option. The bulking agent is composed of pyrolytic carbon coated beads suspended in a beta-glucan and water-based carrier gel.

Read more about Coloplast’s injectable bulking agents for stress urinary incontinence. 

The Coloplast BoNee bladder injection needle, developed in partnership with doctors, delivers low viscosity medication exactly where it is intended.
Reliable and accurate:

• 4 mm tip needle designed to optimise volume injected
• Protection cap to prevent damage
• Small needle size to reduce bleeding, tissue damage and pain
• Two available sizes to meet your needs: Flexible and strong body

Read more about the BoNee bladder injection needle.